CYCLOSPORINE | A203880 | TEVA PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al 5 patentsANDA 203880, 207606, 204561, 205894Cyclosporine Ophthalmic Emulsion, 0.05% | E.D. Tex. | 2015-08-24 | Terminated 2017-10-16 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$1.32
per ea
Lowest NADAC/Unit
$1.08
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00480407630CYCLOSPORINE 0.05% EYE EMULSION | $1.32 | EA | Generic | — | 2026-06-17 |
| 00480407660CYCLOSPORINE 0.05% EYE EMULSION | $1.08 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.